Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Chengdong Qin"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Angiogenesis is an essential feature of liver cancer. Tumor hypoxia results from abnormal vessel architecture. Numerous studies have sufficiently demonstrated that Tanshinone IIA (Tan IIA) can increase blood flow and enhance microcircul
Externí odkaz:
https://doaj.org/article/f9752682537c44ff80ba01d242ae62fb
Autor:
Chengdong Qin, Siyuan Liu, Shiqi Zhou, Qibo Wang, Xianghou Xia, Jiejie Hu, Xiaohong Yuan, Zongping Wang, Yang Yu, Dening Ma
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundPhosphoinositide 3-kinases (PI3Ks) are lipid enzymes that regulate a wide range of intracellular functions. In contrast to Class I and Class III PI3K, which have more detailed descriptions, Class II PI3K has only recently become the focus o
Externí odkaz:
https://doaj.org/article/fbcef10064194b968b8104d7d2a54a43
Autor:
Xingfei Yu, Chen Wang, Yabing Zheng, Beibei Miao, Jiejie Hu, Xiying Shao, Liming Sheng, Juan Lin, Yuqin Ding, Haojun Xuan, Yingying Ding, Lijie Gong, Weiliang Feng, Chengdong Qin, Daobao Chen, Yang Yu, Hongjian Yang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeTo compare survival in different strategies, preoperative systemic treatment versus upfront surgery, in HER2-positive early breast cancer patients in the real world.MethodsAccording to the actual upfront treatment, eligible patients from 2012
Externí odkaz:
https://doaj.org/article/fb6652e5919e40e9b4f500cb7e5fd595
Autor:
Yuqin Ding, Kaijing Ding, Hongdan Qian, Xingfei Yu, Dehong Zou, Hongjian Yang, Wenju Mo, Xiangming He, Fanrong Zhang, Chengdong Qin, Yurong Zheng, Xiaowen Ding
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231895 (2020)
PURPOSE:To investigate whether estrogen receptor (ER), progesterone receptor (PR) and Ki-67 expression discordance before and after neoadjuvant chemotherapy (NAC) correlates with prognosis and treatment of breast cancer patients. METHODS:The study co
Externí odkaz:
https://doaj.org/article/87a3e12fce764dd19b06c4f58f7ddfb5
Autor:
Yang Yu, Zheng Yabing, Lijie Gong, Juan Lin, Chengdong Qin, Hu Jiejie, Yang Hongjian, Xiying Shao, Yuqin Ding, Xingfei Yu, Weiliang Feng, Haojun Xuan, Daobao Chen, Chen Wang, Liming Sheng
Publikováno v:
Cancer Research. 81:PS13-52
Purpose: To comparing the survival in different strategies, preoperative systemic treatment (PST) versus upfront surgery (US) in patients of HER2-positive early breast cancer in real-world.Methods: Eligible patients from 2012 to 2015 were classified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d1c746b4382d9f47e22e27cc3ffd9c5
https://doi.org/10.1158/1538-7445.sabcs20-ps13-52
https://doi.org/10.1158/1538-7445.sabcs20-ps13-52
Autor:
Chengdong Qin, Fanrong Zhang, Hongjian Yang, Yurong Zheng, Yang Yu, Wenju Mo, Yuqin Ding, Xiaowen Ding, Dehong Zou
Publikováno v:
Cancer Biol Ther
e12082 Background: Patients’ responses to breast cancer neoadjuvant chemotherapy (NACT) differ because of heterogeneous tumor characteristics. Reports about NACT progression are sporadic. In this study, we aimed to evaluate the characteristics and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::399e08ccc07342055672820a65eb50df
https://doi.org/10.1080/15384047.2020.1756707
https://doi.org/10.1080/15384047.2020.1756707
Autor:
Xiying Shao, Hongjian Yang, Lijie Gong, Daobao Chen, Yuqin Ding, Chen Wang, Jiejie Hu, Beibei Miao, Chengdong Qin, Yabing Zheng, Yang Yu, Weiliang Feng, Haojun Xuan, Yingying Ding, Xingfei Yu, Juan Lin, Liming Sheng
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
PurposeTo compare survival in different strategies, preoperative systemic treatment versus upfront surgery, in HER2-positive early breast cancer patients in the real world.MethodsAccording to the actual upfront treatment, eligible patients from 2012
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03587804299828f688c1d3f3b4f20f02
https://doi.org/10.3389/fonc.2021.704842
https://doi.org/10.3389/fonc.2021.704842
Autor:
Xingfei Yu, Chenlu Liang, Yuqin Ding, Yang Yu, Yang Hongjian, Hu Jiejie, Haojun Xuan, Chengdong Qin, Weiliang Feng
Background As the critical regulators for tumorigenesis and progression, long-noncoding RNAs (lncRNAs) are becoming novel prognostic biomarkers for tumor patients. By the levels of lncRNAs expression, the patients with breast carcinoma may be divided
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ea1e30173d2313d26dae262ad648c28
https://doi.org/10.21203/rs.3.rs-196427/v1
https://doi.org/10.21203/rs.3.rs-196427/v1
Autor:
Xiaowen Ding, Xiangming He, Hongdan Qian, Xingfei Yu, Kaijing Ding, Yurong Zheng, Chengdong Qin, Dehong Zou, Hongjian Yang, Fanrong Zhang, Yuqin Ding, Wenju Mo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231895 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231895 (2020)
Purpose To investigate whether estrogen receptor (ER), progesterone receptor (PR) and Ki-67 expression discordance before and after neoadjuvant chemotherapy (NAC) correlates with prognosis and treatment of breast cancer patients. Methods The study co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e416f03bd655c2ac921de2b93aeb4835
http://europepmc.org/articles/PMC7162523
http://europepmc.org/articles/PMC7162523
Autor:
Xiaowen Ding, Xiangming He, Chengdong Qin, Yurong Zheng, Dehong Zou, Wenju Mo, Hongjian Yang, Kaijing Ding, Yuqin Ding, Fanrong Zhang, Wen-Ming Cao
Publikováno v:
Journal of Clinical Oncology. 37:e12079-e12079
e12079 Background: The expression status of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 antigen (Ki-67) divides breast cancer into different subtypes. Changes in these biomarkers during treatment alter the overall treatment decision
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1014f2cb79fc311ab0bfb89d2d5e854d
https://doi.org/10.1200/jco.2019.37.15_suppl.e12079
https://doi.org/10.1200/jco.2019.37.15_suppl.e12079